Biotechnology Value Fund, which put pressure on the company to dissolve and pay out its investors. It cut staff in early 2009, then sought to sell off its assets, and finally dissolved in August 2009. The company's CEOs were: 1991 to 1997: Jeffrey S. Price; prior to joining NTI he had been with Cetus Corporation and then with Chiron Corporation 1997 to 2009: Paul Frieman; he had been CEO of Syntex 2009: William Fletcher, formerly with Teva References External links Defunct companies based in the San Francisco Bay Area Biotechnology companies established in 1987 Biotechnology companies disestablished in 2009 1987 establishments in California 2009 disestablishments in California Callaway family